Pneumococcal infections, caused by the bacterium Streptococcus pneumoniae, remain a significant global public health concern. This Gram-positive bacterium is a leading cause of respiratory tract infections, including pneumonia, otitis media, and sinusitis. Pneumococcal infections can also lead to invasive diseases such as bacteremia and meningitis, particularly in vulnerable populations such as young children, the elderly, and individuals with weakened immune systems. Transmission of S. pneumoniae occurs through respiratory droplets, and colonization in the nasopharynx is common, especially in children. The bacterium possesses various virulence factors, including a polysaccharide capsule that aids in evading the host immune system. When infection occurs, the clinical presentation can vary widely, ranging from mild upper respiratory symptoms to severe pneumonia or life-threatening invasive diseases. Preventive measures for pneumococcal infections include vaccination, with pneumococcal conjugate vaccines (PCVs) and pneumococcal polysaccharide vaccines (PPVs) targeting different age groups. Vaccination has led to a significant reduction in the incidence of pneumococcal diseases, highlighting the importance of immunization in public health efforts.
Title : The role of the humoral innate immune system in evasion of streptococcus pyogenes infections
Francis J. Castellino, University of Notre Dame, United States
Title : Global environmental changes and mosquito-borne diseases in coastal areas
Ranjan Ramasamy, IDFISH Technology, United States
Title : The impact of global antibiotic resistance on the healthcare system, public health, environment and society
Reza Nassiri, Michigan State University, United States
Title : Current topics of adult COVID-19, Influenza, and RS virus patients in Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan
Title : Novel nanotechnology and its potential applications
Stephen Hsu, Augusta University, United States
Title : 2000 years of pandemics: Past, present and future
Claudia Ferreira, Biophytis Sorbonne, France